Overcoming AC220 Resistance of FLT3-ITD by SAR302503

Blood Cancer Journal - United States
doi 10.1038/bcj.2013.40
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

DOCK2: A Novel FLT3/ITD Leukemia Drug Target

Oncotarget
Oncology
2017English

The N676D and G697R Mutations in the Kinase Domain of FLT3 Confer Resistance to the Inhibitor AC220

Haematologica
Hematology
2012English

8-Chloro-Adenosine Activity in FLT3-ITD Acute Myeloid Leukemia

Journal of Cellular Physiology
Clinical BiochemistryCell BiologyPhysiology
2019English

Targeting BTK for the Treatment of FLT3-ITD Mutated Acute Myeloid Leukemia

Scientific Reports
Multidisciplinary
2015English

NOX-driven ROS Formation in Cell Transformation of FLT3-ITD-positive AML

Experimental Hematology
Cancer ResearchGeneticsHematologyMolecular BiologyCell Biology
2016English

ABL2 Suppresses FLT3-ITD-induced Cell Proliferation Through Negative Regulation of AKT Signaling

Oncotarget
Oncology
2017English

DNA Damage on the DOCK in FLT3-ITD-driven Acute Myeloid Leukemia

Haematologica
Hematology
2019English

Tyrosine Kinase Inhibition Increases the Cell Surface Localization of FLT3-ITD and Enhances FLT3-directed Immunotherapy of Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2017English

RIPK3-dependent Cell Death and Inflammasome Activation in FLT3-ITD Expressing LICs

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy